These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14576079)

  • 1. Are cardiovascular and sympathoadrenal effects of human "new pressor protein" preparations attributable to human coagulation beta-FXIIa?
    Papageorgiou PC; Pourdjabbar A; Amfilochiadis AA; Diamandis EP; Boomsma F; Osmond DH
    Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H837-46. PubMed ID: 14576079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme-regulated, noncholinergic sympathoadrenal catecholamine release mediates the cardiovascular actions of human 'new pressor protein' related to coagulation beta-factor XIIa.
    Papageorgiou PC; Simos D; Boomsma F; Rojkjaer R; Osmond DH
    Can J Cardiol; 2009 Apr; 25(4):e100-8. PubMed ID: 19340353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenomedullary catecholamine, pressor and chronotropic responses to human coagulation beta-FXIIa mediated by endogenous kinins.
    Amfilochiadis AA; Backx PH; Floras JS
    J Hypertens; 2008 Jan; 26(1):61-9. PubMed ID: 18090541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sympathoadrenal system mediates the blood pressure and cardiac effects of human coagulation factor XII-related "new pressor protein".
    Mavrogiannis L; Trambakoulos DM; Boomsma F; Osmond DH
    Can J Cardiol; 2002 Oct; 18(10):1077-86. PubMed ID: 12420043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human coagulation factor XII-related "new pressor protein": role of PACAP in its cardiovascular and sympathoadrenal effects.
    Simos D; Boomsma F; Osmond DH
    Can J Cardiol; 2002 Oct; 18(10):1093-103. PubMed ID: 12420044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of bradykinin B2-receptor in the sympathoadrenal effects of 'new pressor protein' related to human blood coagulation factor XII fragment.
    Amfilochiadis AA; Papageorgiou PC; Kogan N; Boomsma F; Osmond DH
    J Hypertens; 2004 Jun; 22(6):1173-81. PubMed ID: 15167453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent blood pressure raising effects of activated coagulation factor XII.
    Mavrogiannis L; Kariyawasam KP; Osmond DH
    Can J Physiol Pharmacol; 1997 Dec; 75(12):1398-403. PubMed ID: 9534952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of new pressor protein in hypertensive anephric hemodialysis patients.
    Pearl RJ; Papageorgiou PC; Goldman M; Amfilochiadis AA; Boomsma F; Rojkjaer R; Geary D; Osmond DH
    Pediatr Nephrol; 2003 Oct; 18(10):1025-31. PubMed ID: 12920630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent 'new pressor protein' related to coagulation factor XII is potentiated by inhibition of angiotensin converting enzyme.
    Osmond DH; Mavrogiannis L; Cotter BR
    J Hypertens; 1998 Mar; 16(3):311-20. PubMed ID: 9557924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated plasma coagulation β-Factor XII-induced vasoconstriction in rats.
    Papageorgiou PC; Yeo EL; Backx PH; Floras JS
    Clin Sci (Lond); 2012 Jun; 122(12):581-90. PubMed ID: 22216926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of two types of renin-angiotensin system inhibitors on the hypertension induced by new pressor protein associated with beta-factor XIIa in rats.
    Pejhan A; Gohari A; Rakhshani MH; Papageorgiou PC; Mustafa MI; Golmohammadi R
    Res Pharm Sci; 2020 Apr; 15(2):174-181. PubMed ID: 32582357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new enzyme-linked immunosorbent assay recognizing both rat and human activated coagulation Factor XII (FXIIa).
    Papageorgiou PC; Yeo EL; Backx PH; Floras JS
    J Immunol Methods; 2012 Feb; 376(1-2):132-8. PubMed ID: 22251663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation factor XIIa-kinin-mediated contribution to hypertension of chronic kidney disease.
    Papageorgiou PC; Chan CT; Yeo EL; Backx PH; Floras JS
    J Hypertens; 2014 Jul; 32(7):1523-33; discussion 1533. PubMed ID: 24733030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nanobody-based method for tracking factor XII activation in plasma.
    de Maat S; van Dooremalen S; de Groot PG; Maas C
    Thromb Haemost; 2013 Sep; 110(3):458-68. PubMed ID: 23349032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor.
    Esnouf MP; Burgess AI; Dodds AW; Sarphie AF; Miller GJ
    Thromb Haemost; 2000 Jun; 83(6):874-81. PubMed ID: 10896241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II facilitation of pressor responses to adrenal field stimulation in pithed rats.
    Vollmer RR; Corey SP; Fluharty SJ
    Am J Physiol; 1988 Jan; 254(1 Pt 2):R95-101. PubMed ID: 2892427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XIIa inhibition by Infestin-4: in vitro mode of action and in vivo antithrombotic benefit.
    Xu Y; Cai TQ; Castriota G; Zhou Y; Hoos L; Jochnowitz N; Loewrigkeit C; Cook JA; Wickham A; Metzger JM; Ogletree ML; Seiffert DA; Chen Z
    Thromb Haemost; 2014 Apr; 111(4):694-704. PubMed ID: 24336918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system.
    Tella SR; Schindler CW; Goldberg SR
    J Pharmacol Exp Ther; 1993 Oct; 267(1):153-62. PubMed ID: 8229742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.